A sharp correction despite fundamentals remaining intact in the case of this Prime Stock!
With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]
Just as it seemed like the sector had turned a corner, President Trump’s talk about imposing tariffs of 25% on imports from India has made pharma sector investors sick with worry prompting a sell-off. This tariff, if it does come into force, will affect some players more than others. One of the companies that it […]
Ride the healthcare theme without the hassle of stock picking!
This company is unlikely to deliver scorching growth rates but is a good fit for investors seeking steady growth.
A comprehensive guide on everything you need to know about MF expense ratio
Our pick in the capital intensive hospital sector.
A key player in an entertainment avenue that hasn’t gone out of fashion!
This stock has run up significantly since our BUY call. Find out why we are moving it to a HOLD and what that means.
Looking at the consumer electricals space through the lens of the Q1 FY 25 results.
Why we are moving this API stock from ‘Book Profit’ to ‘Sell’.
Results update for 10 of our Prime Stocks.
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
